Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

Wed, 02.09.2026       Aardvark Therapeutics

A securities class action alleges Aardvark Therapeutics promised investors a "99% gut-restricted" drug with "no serious adverse events" and Phase 3 data in early 2026; instead, cardiac observations paused the HERO trial and the FDA imposed a full clinical hold.NEW YORK, Sept. 2, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP alerts investors in Aa...